Position in OGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,560,953
-$2,958,190 QoQ
Shares Held
594,483
-34.6% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $365,428,487 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
669,135 | $169,940,215 | |
| 2 | LLY |
ELI LILLY & Co
|
87,023 | $104,378,005 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
290,881 | $36,749,905 | |
| 4 | GSK |
GSK plc
|
504,171 | $26,428,643 | |
| 5 | SNY |
Sanofi
|
206,873 | $8,825,202 | |
| 6 | AMGN |
Amgen Inc
|
21,869 | $7,919,202 | |
| 7 | PFE |
Pfizer Inc
|
180,092 | $4,336,615 | |
| 8 | MRK |
Merck & Co., Inc.
|
30,254 | $3,887,639 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,560,953 | 594,483 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,519,143 | 909,225 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,141,577 | 668,687 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,824,060 | 188,436 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,016,942 | 68,297 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $269,261 | 18,047 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,887,139 | 203,196 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||